Artemisinin
Top View
- Nanoparticles Formulations of Artemisinin and Derivatives As Potential Therapeutics for the Treatment of Cancer, Leishmaniasis and Malaria
- The Antimalaria Agent Artemisinin Exerts Antiangiogenic Effects In
- CURRENT WORK PLAN New Monographs for Inclusion in the International Pharmacopoeia and Revision of Related Monographs
- Enhancement of Oral Bioavailability of Functional Ingredients by Complexation with Cyclodextrin
- Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: a Review
- Design and Development of Nanostructured Co Delivery Of
- A Practical Handbook on the Pharmacovigilance of Antimalarial
- Assessment of the Effect of Dihydroartemisinin-Sodium Valproate Combination on Some Behavioural Activities in Mice
- Drug Repositioning in the Treatment of Malaria and TB
- WHO Technical Document of the Use of Non-Pharmaceutical Forms of Artemisia
- Prediction of Pharmacological and Xenobiotic Responses to Drugs Based on Time Course Gene Expression Profiles
- Antimalarial Agents Modified at the C-16 Position of Artemisinin; Part B: Lead Optimization of Falcipain-2 and Falcipain-3 Inhibitors
- The WHO Guidelines for the Treatment of Malaria (MTG)
- Pharmacological Modulators of Autophagy As a Potential Strategy for the Treatment of COVID-19
- (DHA/PQP) FIXED DOSE COMBINATION TABLETS in the 21St EDITION of the WHO MODEL LISTS of ESSENTIAL MEDICINES
- Supplementary Information
- STILBESTROL -- Gynaecological and Obstetric Complications After in Utero Exposure
- Liver Disease